✦ LIBER ✦

c-Met expression in tall cell variant papillary carcinoma of the thyroid

✍ Scribed by Heather C. Nardone; Amy F. Ziober; Virginia A. LiVolsi; Susan J. Mandel; Zubair W. Baloch; Randal S. Weber; Rosemarie Mick; Barry L. Ziober

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 315 KB
Volume: 98
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.11638

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

BACKGROUND

Tall cell variant papillary carcinoma of the thyroid demonstrates unusually aggressive clinical behavior compared with the usual form of papillary thyroid carcinoma. The proto‐oncogene c‐met encodes a tyrosine kinase receptor known to influence cell invasion. This current study examined c‐Met expression in tall cell variant tumors compared with other types of papillary thyroid carcinoma and benign thyroid disease.

METHODS

c‐Met expression in 60 archived thyroid specimens was evaluated by immunohistochemical staining.

RESULTS

Tall cell variant specimens expressed significantly greater levels of c‐Met than other forms of papillary thyroid carcinoma and benign thyroid disease (P < 0.0001). c‐Met expression was significantly different for the following pairs of histologies: tall cell variant versus usual papillary carcinoma of the thyroid (P < 0.0001), tall cell variant versus follicular variant papillary thyroid carcinoma (P < 0.0001), tall cell variant versus benign thyroid (P < 0.0001), and usual papillary carcinoma of the thyroid versus benign thyroid (P = 0.005). In addition, for all types of papillary carcinomas evaluated, c‐Met expression was significantly higher in specimens with extracapsular spread (P = 0.01) and skeletal muscle invasion (P = 0.02), and approached significance for specimens with lymphatic invasion (P = 0.06). After adjusting for extracapsular spread, c‐Met expression was still found to be associated significantly with tall cell histology (P < 0.0001).

CONCLUSIONS

c‐Met expression is a significant marker for tall cell variant papillary carcinoma of the thyroid and its invasive behavior. This finding may explain the unusually aggressive behavior of this tumor and suggests a role for c‐Met in the early identification of patients with tall cell variant thyroid disease. Cancer 2003;98:1386–93. © 2003 American Cancer Society.

DOI 10.1002/cncr.11638

📜 SIMILAR VOLUMES

The tall cell variant of papillary carci

The tall cell variant of papillary carcinoma of the thyroid

✍ Filie, Armando C. ;Chiesa, Andres ;Bryant, Bonita R. ;Merino, Maria J. ;Sobel, M 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB 👁 2 views

## Background: The tall cell variant of papillary carcinoma of the thyroid (tcv) is characterized by the proliferation of oxyphilic, tall, columnar cells with a height-to-width ratio of at least 2:1. tcv exhibits more aggressive clinical behavior than conventional thyroid papillary carcinoma (cpc).

Cytopathology of high-grade papillary th

Cytopathology of high-grade papillary thyroid carcinomas: Tall-cell variant, diffuse sclerosing variant, and poorly differentiated papillary carcinoma

✍ N. Paul Ohori; Karen E. Schoedel 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

Cytologic reports of the aggressive tall-cell and diffuse sclerosing variants of papillary carcinoma have emphasized features such as tall and large cells, increased nuclear size, nuclear pleomorphism, intranuclear pseudoinclusions, three-dimensional tissue fragments, squamous-like cells, and dense

Tall cell variant of papillary thyroid c

Tall cell variant of papillary thyroid carcinoma: Its characteristic features demonstrated by fine-needle aspiration cytology and immunohistochemical study

✍ Makoto Urano; Yuka Kiriyama; Yasunari Takakuwa; Makoto Kuroda 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB

## Abstract Tall cell variant (TCV) of papillary thyroid carcinoma is a rare tumor, which is usually associated with poor outcome, and pathologists often face the dilemma of proper diagnosis of TCV, not only by cytology but also histology. To allow surgeons to determine aggressiveness of the tumor

Anaplastic spindle-cell squamous carcino

Anaplastic spindle-cell squamous carcinoma arising in association with tall-cell papillary cancer of the thyroid: A potential pitfall

✍ Carol A. Saunders; Ritu Nayar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 2 views

Transformation of a differentiated thyroid carcinoma is an infrequent occurrence and is usually associated with a dismal prognosis. Following a long-standing history of papillary carcinoma of the thyroid, the patient in the present report developed anaplastic thyroid carcinoma. The anaplastic compon

Anaplastic spindle-cell squamous carcino

Anaplastic spindle-cell squamous carcinoma arising in association with tall-cell papillary cancer of the thyroid: A potential pitfall

✍ Carol A. Saunders; Ritu Nayar 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

Expression of EDA/EDB isoforms of fibron

Expression of EDA/EDB isoforms of fibronectin in papillary carcinoma of the thyroid

✍ Scarpino, Stefania; Stoppacciaro, Antonella; Pellegrini, Caterina; Marzullo, Ant 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB 👁 2 views

Cellular fibronectins containing the extracellular domain A or B (EDA and EDB) are particularly abundant in fetal and neoplastic tissues. The presence of EDA and EDB was investigated in 28 cases of papillary carcinoma of the thyroid using IST-9 and BC-1 monoclonal antibodies. Immunostaining for EDA